Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

PYXS Pyxis Oncology, Inc. Common Stock
$1.84 8.88% +0.15
Notify me if price changes either direction
Interactive Brokers Logotype

Buy PYXS stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Pyxis Oncology, Inc. Common Stock (PYXS)

Loading

Key Stats

Market cap. 219.8M
Enterprise value 125.0M
Trailing PE -1.4296875335276
Forward PE -1.5165466
PEG Ratio -0.042890626005828
Enterprise to EBITDA -1.461
Enterprise to revenue 11.321
Price to book MRQ 9.333333
Price to sales TTM 18.181376

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 11.0M
EBITDA -85526000
Diluted EPS TTM -1.4
Total Cash (MRQ) 33.0M
Current ratio (MRQ) 1.337
Operating Cash Flow (TTM) -67910000

PYXS trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent PYXS News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.